Antibiotic Prophylaxis with Piperacillin–Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study-Reference-Cited by-同舟云学术

Antibiotic Prophylaxis with Piperacillin–Tazobactam Reduces Post-Operative Infectious Complication after Pancreatic Surgery: An Interventional, Non-Randomized Study

Published:2020-10-23 Issue: Volume: Page:
ISSN:1096-2964
Container-title:Surgical Infections
language:en
Short-container-title:Surgical Infections

Author:

De Pastena Matteo¹,Paiella Salvatore¹,Azzini Anna Maria²,Zaffagnini Amina²,Scarlini Luigi²,Montagnini Greta¹,Maruccio Martina¹,Filippini Chiara¹,Romeo Francesco¹,Mazzariol Annarita³⁴,Lo Cascio Giuliana³⁴,Bazaj Alda³,Secchettin Erica¹,Bassi Claudio¹,Salvia Roberto¹

Affiliation:

1. General and Pancreatic Surgery Department, Pancreas Institute, University and Hospital Trust of Verona, Verona, Italy.

2. Infectious Diseases Unit, Department of Diagnostic and Public Health, Department of Pathology and Diagnostic, University of Verona, Verona, Italy.

3. Department of Diagnostic and Public Health, Microbiology Division, Department of Pathology and Diagnostic, University of Verona, Verona, Italy.

4. Microbiology and Virology Operating Unit, Department of Pathology and Diagnostic, University of Verona, Verona, Italy.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Microbiology (medical),Surgery

Link

https://www.liebertpub.com/doi/pdf/10.1089/sur.2020.260

Reference38 articles.

1. Resistance in Gram-Negative Bacteria: Enterobacteriaceae

2. Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study

3. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

4. Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

5. 5. World Health Organization. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. Geneva; WHO, 2017.

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical prophylaxis in pancreatoduodenectomy: Is cephalosporin still the drug of choice in patients with biliary stents in situ?;Pancreatology;2024-09

2. Piperacillin/tazobactam for surgical prophylaxis during pancreatoduodenectomy: meta-analysis;BJS Open;2024-05-08

3. Comparing cefazolin/metronidazole, piperacillin‐tazobactam, or cefoxitin as surgical antibiotic prophylaxis in patients undergoing pancreaticoduodenectomy: A retrospective cohort study;Journal of Surgical Oncology;2024-04-25

4. Antibiotic prophylaxis with piperacillin–tazobactam reduces organ/space surgical site infection after pancreaticoduodenectomy: a retrospective and propensity score-matched analysis;BMC Cancer;2024-02-23

5. Association of cephalosporin resistance in intraoperative biliary cultures with surgical site infections in patients undergoing pancreaticoduodenectomy. A retrospective cohort study;HPB;2024-02